Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Board has granted a 60% evaluation for the veteran's chronic hepatitis C, effective from February 9, 1995.

The deciding factor: The clinical evidence showed moderate weight loss, fatigue, abdominal pain and cramping, depression, and mild liver enlargement. The Board found that these symptoms warranted a 60% evaluation based on minimal liver damage with associated fatigue, anxiety, and gastrointestinal disturbance of lesser degree and frequency but necessitating dietary restriction or other therapeutic measures.

Claimed conditions
Chronic Hepatitis C, Membranous Glomerulonephritis
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
60%
Decision date
May 3, 2000
Citation
0011709

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0011709.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.